Magnetar Financial
BEAM icon

Magnetar Financial’s Beam Therapeutics BEAM Stock Holding History

Magnetar Financial’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-36,172
Closed -$870K – 387
2023
Q3 		$870K Buy
36,172
+6,255
+21% +$168K 0.02% 269
2023
Q2 		$955K Sell
29,917
-10,925
-27% -$355K 0.02% 275
2023
Q1 		$1.25M Buy
40,842
+29,470
+259% +$1.16M 0.02% 356
2022
Q4 		$445K Buy
+11,372
New +$509K 0.01% 620
2022
Q1 		– Sell
-12,490
Closed -$995K – 1333
2021
Q4 		$995K Buy
+12,490
New +$1.07M 0.01% 807

Other funds holding BEAM

ARK Investment Management
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Farallon Capital Management
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Nikko Asset Management Americas
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Magnetar Financial's BEAM Position: Q4 2023 in Review

Magnetar Financial sold out of Beam Therapeutics (BEAM) in Q4 2023, closing a stake of 36,172 shares — an estimated $870K sold.

Magnetar Financial first reported a position in BEAM in Q4 2021 and held it in 5 quarters. The position peaked at $1.25M in Q1 2023. 185 funds tracked by Wall St. Rank hold BEAM as of Q4 2023.

  • Magnetar Financial reported no remaining Beam Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Magnetar Financial sold 36,172 Beam Therapeutics shares in Q4 2023, an estimated $870K.
  • Magnetar Financial first reported a position in Beam Therapeutics in Q4 2021 and held it in 5 quarters.
  • Magnetar Financial's Beam Therapeutics position peaked at $1.25M in Q1 2023.
  • 185 funds tracked by Wall St. Rank held Beam Therapeutics as of Q4 2023.

Based on Magnetar Financial's 13F filing for Q4 2023, filed 13 Feb 2024.